KOSDAQ - Delayed Quote KRW

Genoray Co., Ltd. (122310.KQ)

Compare
5,670.00 -60.00 (-1.05%)
At close: 3:30 PM GMT+9
Loading Chart for 122310.KQ
DELL
  • Previous Close 5,730.00
  • Open 5,820.00
  • Bid 5,660.00 x --
  • Ask 5,680.00 x --
  • Day's Range 5,650.00 - 5,820.00
  • 52 Week Range 5,490.00 - 7,160.00
  • Volume 8,374
  • Avg. Volume 35,113
  • Market Cap (intraday) 74.172B
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield 160.00 (2.79%)
  • Ex-Dividend Date Apr 2, 2024
  • 1y Target Est --

Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It offers C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

www.genoray.com

329

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 122310.KQ

View More

Performance Overview: 122310.KQ

Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

122310.KQ
17.05%
KOSPI Composite Index
7.51%

1-Year Return

122310.KQ
10.77%
KOSPI Composite Index
2.54%

3-Year Return

122310.KQ
31.39%
KOSPI Composite Index
15.58%

5-Year Return

122310.KQ
3.88%
KOSPI Composite Index
17.62%

Compare To: 122310.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 122310.KQ

View More

Valuation Measures

Annual
As of 11/28/2024
  • Market Cap

    74.17B

  • Enterprise Value

    88.55B

  • Trailing P/E

    10.18

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.71

  • Price/Book (mrq)

    0.80

  • Enterprise Value/Revenue

    0.81

  • Enterprise Value/EBITDA

    5.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.45%

  • Return on Assets (ttm)

    6.62%

  • Return on Equity (ttm)

    10.95%

  • Revenue (ttm)

    108.42B

  • Net Income Avi to Common (ttm)

    10.24B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.11B

  • Total Debt/Equity (mrq)

    27.24%

  • Levered Free Cash Flow (ttm)

    174.89M

Research Analysis: 122310.KQ

View More

Company Insights: 122310.KQ

Research Reports: 122310.KQ

View More

People Also Watch